Related Experiment Video
Updated: Dec 2, 2025
Treatment Model for Young Patients with Psychogenic Erectile Dysfunction and Resultant Infertility
Published on: May 30, 2025
MODERN ENDOVASCULAR TREATMENT METHODS FOR ERECTILE DYSFUNCTION: A CRITICAL ANALYSIS
Magdalena Piegza1, Mateusz Paterak2, Michał Błachut1
1CHAIR AND DEPARTMENT OF PSYCHIATRY IN TARNOWSKIE GORY, SCHOOL OF MEDICINE WITH THE DIVISION OF DENTISTRY IN ZABRZE, POLAND, MEDICAL UNIVERSITY OF SILESIA IN KATOWICE, ZABRZE, POLAND.
Insights
Endovascular treatment for erectile dysfunction (ED) shows promise for select men with vascular causes. Further research is needed to identify optimal patient candidates for long-term success with percutaneous angioplasty.
Area of Science:
- Cardiovascular Medicine
- Urology
- Interventional Radiology
Background:
- Erectile dysfunction (ED) frequently coexists with coronary artery disease (CAD), with high prevalence in both conditions.
- Vascular causes of ED often correlate with significant arterial blockages in penile vasculature.
- A link exists between the severity of coronary artery lesions and the intensity of erectile dysfunction in CAD patients.
Purpose of the Study:
- To systematically review the benefits and drawbacks of non-surgical endovascular treatments for vasculogenic erectile dysfunction.
- To analyze existing studies on percutaneous angioplasty for ED treatment.
Main Methods:
- Systematic review and analysis of seven studies evaluating percutaneous angioplasty for erectile dysfunction.
- Assessment of study limitations and formulation of conclusions based on the evidence.
Main Results:
- Endovascular procedures targeting penile arteries are demonstrated to be safe in carefully selected male patient cohorts.
- Percutaneous angioplasty has been assessed as a treatment modality for ED in the reviewed literature.
Conclusions:
- Endovascular treatment for ED is safe for a specific group of men.
- Further research is essential to define patient selection criteria for optimal long-term outcomes of endovascular ED treatment.
Objective:
75% of men with coronary artery disease confirmed by coronarography have erectile dysfunction in history, while 75% of patients with a vascular etiology of ED have significant stenoses in penile arterial vascularization. Patients with coronary artery disease have shown a relationship between the range of the lesions in the coronary vessels and erectile dysfunction intensity. This paper aims at attempting to systematize the knowledge of the benefits and drawbacks of nonsurgical endovascular treatment methods for erectile dysfunction with confirmed vascular causes. It analyzes seven studies which assess the results of erectile dysfunction treatment with percutaneous angioplasty. It also mentions the limitations of the cited works and formulates relevant conclusions.
Conclusion:
Conclusions: The analysis shows that endovascular procedures in erection-related arteries are safe in a specially selected group of men. It is necessary to conduct further studies to define an appropriate group of patients who have a chance of benefiting optimally from the endovascular treatment of erectile dysfunction in a long-term follow-up.
More Related Videos
03:51Author Spotlight: Advanced Treatment of Seminal Duct Blockage Employing Endoscopy-Mediated Semen Channel Refluviation
Published on: December 8, 2023
13:48Reduction of Radiation Exposure during Endovascular Treatment of Peripheral Arterial Disease Combining Fiber Optic RealShape Technology and Intravascular Ultrasound
Published on: April 21, 2023
Related Concept Videos
01:18Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
01:28Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
01:27Peripheral Artery Disease III: Interprofessional Care